by

Joseph

I have some news which could be of value to people with mild to moderate asthma. Hoffmann-La Roche is conducting a clinical trial for mild to moderate asthmatics who use reliever inhalers. The study drug, if approved, is intended to improve lung function in asthmatic patients.

As a CureClick Ambassador I want to share this information with my readers because it could be helpful in the treatment of the disease.

Information about the clinical trial and eligibility requirements are listed below:

 Title

Patients with mild or moderate asthma

Condition

mild or moderate asthma

Phase

Phase 3

Description

This study is for patients who have mild or moderate asthma and are using a reliever inhaler. If approved, it is hoped that the study drug will improve your lung function and overall symptoms of asthma.

Enrollment

300

Sponsor

Hoffmann-La Roche

Age Range

18-75 years old

Stage

Recruiting

For trial eligibility questionnaire and full trial details, please visit our partner TrialReach.

For those of you whom are not familiar with clinical trials, here's some information that you can use:

What Are Clinical Trials?

Clinical trials are research studies to determine whether investigational drugs or treatments are safe and effective for humans.

All investigational devices and medicines must undergo several clinical trials, often times these clinical trials require thousands of people.

Why participate in a clinical trial?

People whom are eligible will have access to new investigational treatments that would be available to the general public only upon approval.

People whom are eligible for clinical trials will also receive study-related medical care and attention from clinical staff at research facilities.

Clinical trials offer hope for many people and gives researchers a chance to find better treatment for others in the future.

Disclaimer: I am not participating in this clinical trial. I am providing this information to my readers as a CureClick Ambasssador. Click on My Relationship To CureClick to learn why I'm talking about clinical trials.

curec.lk/1Gb4toG

http://curec.lk/1BHcYBM

23 Jesus replied, "The hour has come for the Son of Man to be glorified. 24 I tell you the truth, unless a kernel of wheat falls to the ground and dies, it remains only a single seed. But if it dies, it produces many seeds. 25 The man who loves his life will lose it, while the man who hates his life in this world will keep it for eternal life. John 12:23-25

***Like us on Facebook!!!***

I'm living fit, healthy and happy_(SM). Are you?

Google+